Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease (OSCAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04376684
Recruitment Status : Recruiting
First Posted : May 6, 2020
Last Update Posted : April 2, 2021
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 23, 2021
Estimated Study Completion Date : August 23, 2021